AIM: To investigate the plasma levels of atrial and brain natriuretic peptides (ANP and BNP), cardiac troponin I (cTnI) and C-reactive protein (CRP) as prognostic factors for survival in patients with sepsis. METHOD: Evaluation of serum levels of ANP, BNP, cTnI and CRP of patients on admission to an intensive care unit, two days later, and on the day of discharge from the intensive care unit or on the day of death. RESULTS: ANP levels were significantly higher in the nonsurviving patients (day 1: 70.00+/-49.54 pg/mL; day 2: 138.85+/-143.15 pg/mL; and died/discharged day: 375.70+/-262.66 pg/mL) than surviving patients (day 1: 23.96+/-29.93 pg/mL; day 2: 10.06+/-6.03 pg/mL; died/discharged day: 6.68+/-100.98 pg/mL, P<0.001). The BNP levels were significantly higher in the nonsurvivors (day 1: 254.78+/-308.62 pg/mL; day 2: 383.22+/-307.19 pg/mL; and died/discharged day: 696.47+/-340.33 pg/mL), than survivors (day 1: 13.72+/-12.95 pg/mL; day 2: 7.20+/-5.85 pg/mL; died/discharged day: 4.51+/-4.64 pg/mL, P<0.001). The cTnI levels were significantly higher in the nonsurviving patients (day 2: 0.16+/-0.38 mug/L; died/discharged day: 0.78+/-2.48 mug/L) than surviving patients (day 2: 0.04+/-0.07 mug/L; died/discharged day: 0.02+/-0.01 mug/L, P<0.05). The CRP levels were significantly higher in the nonsurvivors (day 2: 119.3+/-71.5 mg/L; and died/discharged day: 145.7+/-74.7 mg/L) than survivors (day 2: 57.0+/-29.7 mg/L; died/discharged day: 26.8+/-24.0 mg/L, P<0.05). There were no significant differences between nonsurvivors and survivors for cTnI and CRP on day 1. CONCLUSION: With the exception of cTnI and CRP on day 1, all of the parameters were significantly powerful to determine nonsurvivors on all days. Among these variables, BNP was the most powerful diagnostic parameter for the prediction of nonsurvivors on all days.
AIM: To investigate the plasma levels of atrial and brain natriuretic peptides (ANP and BNP), cardiac troponin I (cTnI) and C-reactive protein (CRP) as prognostic factors for survival in patients with sepsis. METHOD: Evaluation of serum levels of ANP, BNP, cTnI and CRP of patients on admission to an intensive care unit, two days later, and on the day of discharge from the intensive care unit or on the day of death. RESULTS: ANP levels were significantly higher in the nonsurviving patients (day 1: 70.00+/-49.54 pg/mL; day 2: 138.85+/-143.15 pg/mL; and died/discharged day: 375.70+/-262.66 pg/mL) than surviving patients (day 1: 23.96+/-29.93 pg/mL; day 2: 10.06+/-6.03 pg/mL; died/discharged day: 6.68+/-100.98 pg/mL, P<0.001). The BNP levels were significantly higher in the nonsurvivors (day 1: 254.78+/-308.62 pg/mL; day 2: 383.22+/-307.19 pg/mL; and died/discharged day: 696.47+/-340.33 pg/mL), than survivors (day 1: 13.72+/-12.95 pg/mL; day 2: 7.20+/-5.85 pg/mL; died/discharged day: 4.51+/-4.64 pg/mL, P<0.001). The cTnI levels were significantly higher in the nonsurviving patients (day 2: 0.16+/-0.38 mug/L; died/discharged day: 0.78+/-2.48 mug/L) than surviving patients (day 2: 0.04+/-0.07 mug/L; died/discharged day: 0.02+/-0.01 mug/L, P<0.05). The CRP levels were significantly higher in the nonsurvivors (day 2: 119.3+/-71.5 mg/L; and died/discharged day: 145.7+/-74.7 mg/L) than survivors (day 2: 57.0+/-29.7 mg/L; died/discharged day: 26.8+/-24.0 mg/L, P<0.05). There were no significant differences between nonsurvivors and survivors for cTnI and CRP on day 1. CONCLUSION: With the exception of cTnI and CRP on day 1, all of the parameters were significantly powerful to determine nonsurvivors on all days. Among these variables, BNP was the most powerful diagnostic parameter for the prediction of nonsurvivors on all days.
Entities:
Keywords:
C-reactive protein; Intensive care unit; Natriuretic peptides; Prognosis; Sepsis; Troponin I
Authors: E Presterl; T Staudinger; M Pettermann; A Lassnigg; H Burgmann; S Winkler; M Frass; W Graninger Journal: Am J Respir Crit Care Med Date: 1997-09 Impact factor: 21.405
Authors: K J Hartemink; A B Groeneveld; M C de Groot; R J Strack van Schijndel; G van Kamp; L G Thijs Journal: Crit Care Med Date: 2001-01 Impact factor: 7.598
Authors: J E Adams; G S Bodor; V G Dávila-Román; J A Delmez; F S Apple; J H Ladenson; A S Jaffe Journal: Circulation Date: 1993-07 Impact factor: 29.690
Authors: Roderick H Tung; Christine Garcia; Alexander M Morss; Richard M Pino; Michael A Fifer; B Taylor Thompson; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; James L Januzzi Journal: Crit Care Med Date: 2004-08 Impact factor: 7.598
Authors: Francis Bessière; Safia Khenifer; Julie Dubourg; Isabelle Durieu; Jean-Christophe Lega Journal: Intensive Care Med Date: 2013-04-18 Impact factor: 17.440
Authors: Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold Journal: Nat Rev Cardiol Date: 2020-05-22 Impact factor: 32.419
Authors: Helge Røsjø; Marjut Varpula; Tor-Arne Hagve; Sari Karlsson; Esko Ruokonen; Ville Pettilä; Torbjørn Omland Journal: Intensive Care Med Date: 2010-10-12 Impact factor: 17.440